Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
CN Stock MarketDetailed Quotes
China National Accord Medicines Corporation (000028)
- 23.80
- -0.10-0.42%
Market Closed May 22 15:00 CST
13.25BMarket Cap12.09P/E (TTM)
23.94High23.70Low17.50KlotVolume23.90Open23.90Prev Close41.70MTurnover0.37%Turnover Ratio11.66P/E (Static)556.57MShares27.4352wk High0.70P/B11.38BFloat Cap23.7052wk Low26.29Limit Up478.05MShs Float68.17Historical High21.51Limit Down1.00%Range %-4.45Historical Low0.37Dividend TTM23.82Avg Price9.17KlotAsk1.54%Div Yield TTM100Lot Size7.67KlotBid
China National Accord Medicines Corporation (000028) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -6.54%5.18B | 5.32%7.8B | 3.90%5.65B | 13.16%6.8B | -3.17%5.54B | 13.94%7.41B | 4.74%5.43B | 5.39%6.01B | -3.75%5.72B | 8.08%6.5B |
| Notes receivable and accounts receivable | 0.56%24.29B | 9.48%21.93B | 2.25%25.2B | 4.64%24.13B | 1.20%24.15B | 3.75%20.03B | 2.52%24.65B | 1.77%23.06B | 18.01%23.86B | 29.89%19.31B |
| -Notes receivable | -31.19%387.07M | -39.92%395.01M | -23.09%395.99M | -36.24%385.26M | -35.64%562.5M | -42.84%657.47M | -37.87%514.9M | -17.98%604.22M | -4.91%874.03M | 4.37%1.15B |
| -Accounts receivable | 1.32%23.9B | 11.16%21.54B | 2.79%24.81B | 5.73%23.75B | 2.60%23.59B | 6.70%19.38B | 3.96%24.13B | 2.44%22.46B | 19.10%22.99B | 31.93%18.16B |
| Other receivables (including interest and dividends) | -16.44%611.95M | -18.78%591.74M | -19.77%557.91M | -23.89%611.1M | -15.40%732.38M | -9.95%728.54M | -2.79%695.43M | 9.07%802.97M | 14.07%865.65M | 28.14%809.01M |
| -Dividend receivable | ---- | ---- | ---- | -52.50%33.43M | ---- | ---- | ---- | 321.08%70.38M | ---- | ---- |
| -Other receivable | ---- | ---- | ---- | -21.15%577.67M | ---- | -9.95%728.54M | ---- | 1.82%732.59M | ---- | 28.14%809.01M |
| Contractual assets | -82.39%2.07M | -74.52%2.98M | -34.20%6.9M | -30.85%7.57M | 25.26%11.75M | 10.60%11.7M | -29.09%10.49M | -35.10%10.94M | -52.06%9.38M | -41.39%10.58M |
| Advance payment | -48.05%283.9M | -41.01%408.22M | -53.17%282.11M | -31.74%344.84M | -7.36%546.47M | 11.62%692.05M | 20.05%602.43M | -8.39%505.22M | 7.82%589.91M | -26.57%620M |
| Inventories | 5.64%8.47B | 9.66%8.12B | -0.60%8.34B | -3.78%8.06B | -2.71%8.02B | -7.30%7.41B | -1.08%8.39B | -1.57%8.38B | -4.52%8.24B | 1.95%7.99B |
| Receivable financing | 22.21%1.15B | -6.43%1B | 36.04%983.39M | -22.19%730.29M | 59.08%939.47M | 17.26%1.07B | 23.28%722.85M | 78.54%938.54M | -11.75%590.55M | -30.61%913.98M |
| Other current assets | 65.08%323.3M | 48.94%332.75M | -15.51%146.09M | -4.68%174.87M | 14.78%195.84M | 4.10%223.42M | 4.66%172.9M | 37.41%183.46M | 30.34%170.63M | 20.46%214.62M |
| Total current assets | 0.42%40.31B | 6.97%40.2B | 1.20%41.17B | 2.43%40.86B | 0.20%40.14B | 3.32%37.58B | 2.47%40.68B | 2.71%39.89B | 8.47%40.06B | 14.70%36.37B |
| Non Current assets | ||||||||||
| Other equity investment | 27.25%12.42M | 27.25%12.42M | -68.07%9.76M | -68.07%9.76M | -68.07%9.76M | -68.07%9.76M | -2.27%30.57M | -2.27%30.57M | -2.27%30.57M | -2.27%30.57M |
| Other non-current financial assets | -20.03%96.8M | -20.67%99.12M | -18.64%121.04M | -21.06%121.04M | -21.06%121.04M | -26.24%124.95M | -26.34%148.77M | -24.09%153.33M | -18.48%153.33M | -10.30%169.39M |
| Investment real estate | -3.57%81.47M | -3.48%82.34M | -19.63%83.28M | -20.94%84.17M | -21.36%84.49M | -24.15%85.31M | -3.46%103.62M | -1.92%106.46M | -1.40%107.44M | 2.98%112.47M |
| Long-term equity investment | 6.29%3.24B | 7.52%3.17B | 6.62%3.08B | 5.64%3.05B | 6.57%3.05B | 7.20%2.94B | 8.40%2.89B | 9.00%2.89B | 7.56%2.86B | 6.51%2.75B |
| Fixed assets | ---- | ---- | ---- | -2.74%819.71M | ---- | 0.46%870.19M | ---- | 1.33%842.83M | ---- | 1.90%866.24M |
| Constru in process | ---- | ---- | ---- | -22.06%14.84M | ---- | -64.43%12.6M | ---- | -49.59%19.04M | ---- | 0.76%35.44M |
| Intangible assets | -14.97%397.96M | -15.19%406.69M | -22.70%449.1M | -22.00%463.33M | -22.69%468.05M | -22.10%479.54M | -7.62%580.97M | -7.97%593.98M | -6.83%605.38M | -4.93%615.59M |
| Goodwill | -13.66%1.6B | -13.66%1.6B | -32.32%1.86B | -32.32%1.86B | -32.32%1.86B | -32.32%1.86B | 0.00%2.75B | 0.00%2.75B | -0.12%2.75B | -0.12%2.75B |
| Long deferred expense | -28.10%309.17M | -28.32%335.23M | -28.75%357.86M | -25.26%387.04M | -16.37%430.02M | -11.19%467.67M | -3.50%502.27M | -3.67%517.86M | -5.68%514.21M | -8.03%526.58M |
| Deferred tax assets | 25.58%322.3M | 23.78%308.72M | 21.30%298.9M | 18.31%279.27M | 15.56%256.65M | 13.12%249.41M | 18.92%246.4M | 27.76%236.04M | 21.60%222.09M | 19.01%220.48M |
| Usufruct assets | -28.01%1.79B | -27.37%1.89B | -28.28%2.09B | -27.00%2.25B | -18.21%2.49B | -8.01%2.6B | 8.35%2.92B | 15.01%3.08B | 18.23%3.04B | 11.93%2.82B |
| Other non current assets | -28.64%196.17M | -31.19%192.48M | -25.97%218.89M | -24.00%227.2M | -13.08%274.91M | -9.14%279.72M | -16.76%295.69M | -23.45%298.95M | -23.83%316.26M | -29.53%307.86M |
| Total non current assets | -10.80%8.82B | -10.81%8.9B | -16.91%9.39B | -16.93%9.56B | -13.81%9.88B | -10.91%9.98B | 2.39%11.3B | 4.25%11.51B | 4.66%11.47B | 2.69%11.2B |
| Total assets | -1.80%49.12B | 3.24%49.1B | -2.74%50.56B | -1.90%50.43B | -2.92%50.02B | -0.03%47.56B | 2.45%51.98B | 3.05%51.41B | 7.60%51.52B | 11.63%47.57B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -32.40%2.52B | -13.75%2.6B | -17.79%3.54B | -2.31%4.34B | -1.94%3.73B | 15.47%3.02B | -2.46%4.3B | 11.71%4.44B | 11.67%3.81B | 107.27%2.61B |
| Notes payable and accounts payable | 4.65%20.52B | 13.35%20.52B | 3.63%21.35B | 2.16%19.83B | -2.21%19.61B | 0.82%18.1B | 2.48%20.6B | 0.15%19.41B | 11.10%20.05B | 17.85%17.95B |
| -Notes payable | 23.14%9B | 18.91%10.16B | 3.94%8.5B | 6.67%8.02B | -5.76%7.31B | 1.94%8.54B | 7.01%8.18B | 0.92%7.52B | 20.07%7.76B | 19.27%8.38B |
| -Accounts payable | -6.35%11.51B | 8.37%10.36B | 3.44%12.85B | -0.70%11.81B | 0.03%12.29B | -0.15%9.56B | -0.30%12.42B | -0.33%11.89B | 6.09%12.29B | 16.63%9.57B |
| Contract liabilities | 21.60%361.49M | 10.94%367.24M | 0.11%294.07M | -26.45%304.5M | -18.24%297.27M | -24.44%331.03M | -36.15%293.73M | -16.53%414M | -26.74%363.59M | -22.96%438.1M |
| Advance receipts | 2.09%17.94M | 6.70%19.97M | 2.92%20.32M | -0.22%19.55M | 2.01%17.58M | 2.86%18.72M | -0.65%19.74M | 5.41%19.59M | 17.03%17.23M | -0.65%18.2M |
| Salaries payable | 0.88%202.91M | -17.61%271.26M | -12.31%254.6M | -16.28%207.69M | -16.70%201.13M | -6.64%329.25M | -10.35%290.34M | -14.50%248.06M | -14.92%241.46M | -22.54%352.65M |
| Taxs payable | 8.48%328.23M | 8.03%324.07M | 9.84%326.02M | 1.49%303.33M | -4.66%302.57M | -19.81%299.97M | -12.53%296.81M | -8.93%298.89M | 3.53%317.36M | -12.79%374.08M |
| Other payable (including interest and dividends) | -36.55%1.19B | -27.83%1.22B | -32.48%817.08M | -11.50%1.55B | 3.13%1.88B | 12.32%1.69B | -12.18%1.21B | -12.37%1.75B | -22.58%1.83B | -27.87%1.51B |
| -Interest payable | -55.14%17.63M | --25.74M | -52.29%16.06M | -31.59%31.88M | 17.25%39.3M | ---- | 56.86%33.67M | 68.73%46.59M | -34.04%33.52M | ---- |
| -Dividend payable | 0.00%10.54M | 0.00%10.54M | 0.00%10.54M | -2.09%10.54M | -2.09%10.54M | -2.09%10.54M | 70.62%10.54M | 42.26%10.76M | 46.62%10.76M | 46.62%10.76M |
| -Other payable | -36.36%1.17B | -29.53%1.19B | -32.20%790.48M | -11.00%1.51B | 2.90%1.83B | 12.42%1.68B | -13.66%1.17B | -13.72%1.7B | -22.55%1.78B | -28.13%1.5B |
| Non current liabilities due within one year | -26.48%710.9M | -21.59%740.45M | -20.12%827.83M | -16.45%872.86M | -8.96%966.98M | -7.35%944.37M | 5.52%1.04B | 4.88%1.04B | 11.84%1.06B | 11.65%1.02B |
| Other current liabilities | 30.70%40.83M | -39.04%41.93M | -18.61%32.78M | -16.23%34.15M | -20.60%31.24M | 8.36%68.79M | -23.68%40.27M | -57.74%40.77M | -17.71%39.35M | 6.34%63.48M |
| Total current liabilities | -4.22%25.9B | 5.25%26.11B | -2.25%27.46B | -0.76%27.46B | -2.47%27.04B | 1.91%24.8B | 0.08%28.09B | 0.32%27.67B | 6.99%27.72B | 15.74%24.34B |
| Current liabilities | ||||||||||
| Long term account payable | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Long term salaries pay | -14.31%611K | -14.31%611K | -10.32%678K | -10.32%678K | -7.64%713K | -7.64%713K | -9.89%756K | -9.89%756K | -10.44%772K | -10.44%772K |
| Specific account payable | ---- | ---- | ---- | 0.00%6.94M | ---- | 0.00%6.94M | ---- | 0.00%6.94M | ---- | 0.00%6.94M |
| Estimate liabilities | -64.11%122.84K | -8.96%311.62K | ---- | ---- | -87.95%342.28K | -87.95%342.28K | --5.4M | --5.4M | --2.84M | --2.84M |
| Deferred tax liabilities | -19.79%89.59M | -18.02%93.87M | -21.31%106.03M | -23.07%107.41M | -20.90%111.7M | -21.60%114.5M | -9.59%134.74M | -9.28%139.62M | -9.93%141.21M | -6.66%146.05M |
| Long term deferred income | 0.29%67.71M | -0.28%68.48M | -6.73%65.29M | -6.97%66.4M | -7.21%67.52M | -7.40%68.68M | -7.46%70M | -7.48%71.38M | -7.46%72.77M | -7.41%74.17M |
| Lease liabilities | -32.22%862.2M | -33.48%912.18M | -34.41%1.02B | -33.17%1.11B | -22.54%1.27B | -5.54%1.37B | 13.69%1.56B | 23.32%1.66B | 25.19%1.64B | 9.37%1.45B |
| Other non current liabilities | -32.48%286.31M | -34.73%284.25M | -23.29%350.43M | -15.40%418.24M | -18.03%424.05M | -23.93%435.5M | -23.32%456.85M | -18.32%494.36M | 0.55%517.35M | 3.30%572.47M |
| Total non current liabilities | -30.26%1.31B | -31.60%1.37B | -30.52%1.55B | -28.15%1.71B | -21.00%1.88B | -11.40%2B | 1.55%2.23B | 8.15%2.38B | 14.26%2.38B | 5.21%2.26B |
| Total liabilities | -5.91%27.21B | 2.50%27.47B | -4.33%29.01B | -2.93%29.18B | -3.94%28.92B | 0.78%26.8B | 0.18%30.33B | 0.90%30.06B | 7.53%30.11B | 14.77%26.59B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%556.57M | 0.00%556.57M | 0.00%556.57M | 0.00%556.57M | 0.00%556.57M | 0.00%556.57M | 0.00%556.57M | 0.00%556.57M | 30.00%556.57M | 30.00%556.57M |
| Capital reserve funds | 0.17%4.27B | 0.17%4.27B | 0.17%4.27B | 0.11%4.27B | 0.00%4.26B | 0.00%4.26B | 0.76%4.26B | 0.76%4.26B | -2.21%4.26B | -2.21%4.26B |
| Surplus reserve funds | 0.00%278.28M | 0.00%278.28M | 0.00%278.28M | 0.00%278.28M | 0.00%278.28M | 0.00%278.28M | 30.00%278.28M | 30.00%278.28M | 30.00%278.28M | 30.00%278.28M |
| Retained profit | 6.91%13.8B | 7.41%13.51B | 2.54%13.33B | 2.85%13.04B | 1.60%12.9B | 2.14%12.58B | 8.63%13B | 9.22%12.68B | 10.62%12.7B | 10.73%12.31B |
| Other composite income | 80.93%-276.28K | 80.93%-276.28K | -118.91%-1.49M | -118.91%-1.49M | -118.42%-1.45M | -118.42%-1.45M | -0.62%7.85M | -0.62%7.85M | -0.51%7.87M | -0.57%7.87M |
| Shareholders equity without minority interests | 5.00%18.9B | 5.32%18.61B | 1.81%18.43B | 2.00%18.14B | 1.09%18B | 1.46%17.67B | 6.65%18.1B | 7.02%17.78B | 7.98%17.8B | 7.99%17.41B |
| Minority interests | -2.87%3.02B | -2.31%3.01B | -12.29%3.12B | -12.74%3.11B | -14.13%3.1B | -13.39%3.09B | 1.70%3.55B | 2.54%3.57B | 6.37%3.62B | 7.36%3.56B |
| Total shareholder equity | 3.84%21.91B | 4.19%21.62B | -0.50%21.55B | -0.46%21.25B | -1.48%21.1B | -1.06%20.76B | 5.81%21.65B | 6.24%21.35B | 7.70%21.42B | 7.88%20.98B |
| Total liabilityies and equity | -1.80%49.12B | 3.24%49.1B | -2.74%50.56B | -1.90%50.43B | -2.92%50.02B | -0.03%47.56B | 2.45%51.98B | 3.05%51.41B | 7.60%51.52B | 11.63%47.57B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm